Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs
| dc.contributor.author | Secret, E. | |
| dc.contributor.author | Smith, K. | |
| dc.contributor.author | Dubljevic, V. | |
| dc.contributor.author | Moore, E. | |
| dc.contributor.author | Macardle, P. | |
| dc.contributor.author | Delalat, B. | |
| dc.contributor.author | Rogers, M.L. | |
| dc.contributor.author | Johns, T.G. | |
| dc.contributor.author | Durand, J.O. | |
| dc.contributor.author | Cunin, F. | |
| dc.contributor.author | Voelcker, N.H. | |
| dc.date.issued | 2013 | |
| dc.description.abstract | We describe the preparation of biodegradable porous silicon nanoparticles (pSiNP) functionalized with cancer cell targeting antibodies and loaded with the hydrophobic anti-cancer drug camptothecin. Orientated immobilization of the antibody on the pSiNP is achieved using novel semicarbazide based bioconjugate chemistry. To demonstrate the generality of this targeting approach, the three antibodies MLR2, mAb528 and Rituximab are used, which target neuroblastoma, glioblastoma and B lymphoma cells, respectively. Successful targeting is demonstrated by means of flow cytometry and immunocytochemistry both with cell lines and primary cells. Cell viability assays after incubation with pSiNPs show selective killing of cells expressing the receptor corresponding to the antibody attached on the pSiNP. | |
| dc.identifier.citation | Advanced healthcare materials, 2013; 2(5):718-727 | |
| dc.identifier.doi | 10.1002/adhm.201200335 | |
| dc.identifier.issn | 2192-2640 | |
| dc.identifier.issn | 2192-2659 | |
| dc.identifier.uri | https://hdl.handle.net/1959.8/125312 | |
| dc.language.iso | en | |
| dc.publisher | Wiley-VCH Verlag GmbH | |
| dc.relation.funding | PHC FAST 2011 Program 24136Y | |
| dc.rights | Copyright 2013 Wiley-VCH GmbH Access Condition Notes: Preprint only available on Open Access | |
| dc.source.uri | https://doi.org/10.1002/adhm.201200335 | |
| dc.subject | antibodies | |
| dc.subject | antineoplastic agents | |
| dc.subject | camptothecin | |
| dc.subject | cell line | |
| dc.subject | diffusion | |
| dc.subject | hydrophobic and hydrophilic interactions | |
| dc.subject | materials testing | |
| dc.subject | nanocapsules | |
| dc.subject | neoplasms | |
| dc.subject | porosity | |
| dc.subject | silicon/chemistry | |
| dc.title | Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs | |
| dc.type | Journal article | |
| pubs.publication-status | Published | |
| ror.fileinfo | 12143169470001831 13143168740001831 9915914118401831_53109919510001831.pdf | |
| ror.mmsid | 9915914118401831 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 9915914118401831_53109919510001831.pdf
- Size:
- 2.19 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version